Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
Ross Liao(Johns Hopkins University), Phillip M. Pierorazio(University of Pennsylvania Health System), Michael H. Johnson(Johns Hopkins University), David J. McConkey(Johns Hopkins University), Hiten D. Patel(Northwestern University), Trinity J. Bivalacqua(University of Pennsylvania), Mohit Gupta(Johns Hopkins University), Noah M. Hahn(Johns Hopkins University), Max Kates(Duke Medical Center), Zeyad Schwen(Johns Hopkins University)
Cited by 61
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k